These findings suggest a model in which astrocytic TDP‐43 dysregulation contributes to pathogenesis in AD and FTD through alterations in neuroimmune signaling and viral susceptibility, potentially due to aberrant host RNA processing. The gene discussed is TARDBP; the disease is Alzheimer disease.